Literature DB >> 6418793

Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development.

N Koch, A W Harris.   

Abstract

We have examined 25 cultured lines of mouse tumor cells for synthesis of the Ii, an Ia-associated polypeptide, by using an anti-Ii monoclonal antibody. Six of the T lymphomas tested did not produce detectable levels of Ii or of surface Ia antigens. Three B lymphomas and two plasmacytomas that express surface Ia antigens were found to synthesize the Ii. In addition, Ii was immunoprecipitated from two of five Ia- pre-B lymphomas, two of four Ia- plasmacytomas, two Ia- myeloid tumors, and two fibroblast cell lines including LM(TK-). Because Ia antigens have so far been found only on cells that also synthesize Ii, we suggest that the Ii is a marker of those cells that in certain states of development or activation express Ia antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6418793

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Alternative proteolytic processing of mouse mammary tumor virus superantigens.

Authors:  F Denis; N H Shoukry; M Delcourt; J Thibodeau; N Labrecque; H McGrath; J S Munzer; N G Seidah; R P Sékaly
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Transcriptional control of the invariant chain gene involves promoter and enhancer elements common to and distinct from major histocompatibility complex class II genes.

Authors:  L Zhu; P P Jones
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

3.  Granulocyte-macrophage colony-stimulating factor elevates invariant chain expression in immature myelomonocytic cell lines.

Authors:  I Klagge; U Kopp; N Koch
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

4.  Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.

Authors:  C Layet; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells.

Authors:  S Jacobson; R P Sekaly; C L Jacobson; H F McFarland; E O Long
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  The gene encoding the Ia-associated invariant chain is located on chromosome 18 in the mouse.

Authors:  K Yamamoto; G Floyd-Smith; U Francke; N Koch; W Lauer; B Dobberstein; R Schäfer; G J Hämmerling
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

7.  Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing.

Authors:  Dalian Zhong; Weiyi Yu; Yuhua Liu; Jing Liu; Jinnian Li
Journal:  Immunogenetics       Date:  2004-11-16       Impact factor: 2.846

8.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

9.  Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.

Authors:  A M Brown; M W Linhoff; B Stein; K L Wright; A S Baldwin; P V Basta; J P Ting
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.

Authors:  Se Hwan Mun; Hee Yeon Won; Paula Hernandez; Hector Leonardo Aguila; Sun-Kyeong Lee
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.